title: NCI Launches Drug Formulary.
abstract: Through its Cancer Therapy Evaluation Program, the NCI has partnered with several pharmaceutical companies to launch the NCI Formulary. The program aims to speed access to drugs for preclinical and clinical studies for investigators at NCI-designated cancer centers.
mesh_terms: D000970:Antineoplastic Agents; D004345:Drug Industry; D004354:Drug Screening Assays, Antitumor; D005569:Formularies as Topic; D006801:Humans; D054547:National Cancer Institute (U.S.); D014481:United States
chemical_list: D000970:Antineoplastic Agents